19 Biotech Stocks With Clinical Trial Outcomes In February

By: via Benzinga
The pharma and biotech space, a defensive sector, has outperformed the broader market. TheiShares NASDAQ Biotechnology Index ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.